Having trouble accessing articles? Reset your cache.

June 19 Financial Quick Takes: Stoke rises after IPO; plus Polaris, Woodford, follow-ons

Stoke catches fire after pricing upsized IPO
Genetic diseases company Stoke Therapeutics Inc. (NASDAQ:STOK) gained $7.57 (42%) to $25.57 in its first day of trading Wednesday after raising $142 million in its IPO. The company priced 7.9 million shares at $18, giving it a valuation of $566.3 million; it had proposed

Read the full 504 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE